XML 33 R2.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Earnings - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Profit or loss [abstract]      
Revenue (Note 21) $ 1,213,028 $ 1,158,519 $ 1,053,019
Cost of sales 924,244 911,644 834,136
Gross profit 288,784 246,875 218,883
Selling, general and administrative expenses 157,486 136,674 122,466
Research expenses 11,196 12,527 12,024
Operating expenses 168,682 149,201 134,490
Operating profit before manufacturing facility closures, restructuring and other related charges 120,102 97,674 84,393
Manufacturing facility closures, restructuring and other related charges (Note 4) 4,328 5,136 7,060
Operating profit 115,774 92,538 77,333
Finance costs (income) (Note 3)      
Interest 29,436 31,690 17,072
Other (income) expense, net (6,238) 3,314 3,810
Finance costs (income) 23,198 35,004 20,882
Earnings before income tax expense 92,576 57,534 56,451
Income tax expense (benefit) (Note 5)      
Current 25,595 17,195 934
Deferred (6,474) (885) 8,868
Income tax expense (benefit) 19,121 16,310 9,802
Net earnings 73,455 41,224 46,649
Net earnings (loss) attributable to:      
Company shareholders 72,670 41,216 46,753
Non-controlling interests 785 8 (104)
Net earnings $ 73,455 $ 41,224 $ 46,649
Earnings per share attributable to Company shareholders (Note 6)      
Basic (in dollars per share) $ 1.23 $ 0.70 $ 0.79
Diluted (in dollars per share) $ 1.22 $ 0.70 $ 0.79